These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 729957)

  • 21. Distribution of acridine orange-stained RNA in neuroblastoma cells during differentiation.
    Lange K; Herken R; Keller K; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jul; 298(3):259-62. PubMed ID: 70760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activation of distinct molecular and cellular phenotypes after induction of differentiation in a human neuroblastoma cell line.
    Gaetano C; Matsumoto K; Thiele CJ
    Cancer Res; 1992 Aug; 52(16):4402-7. PubMed ID: 1322787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine- -hydroxylase activity in mouse neuroblastoma tumors and in cell cultures.
    Anagnoste B; Freedman LS; Goldstein M; Broome J; Fuxe K
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1883-6. PubMed ID: 4505666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multipotent capacity of morphologically intermediate (I-type) human neuroblastoma cells after treatment with differentiation-inducing drugs.
    Ross RA; Bossart E; Spengler BA; Biedler JL
    Prog Clin Biol Res; 1991; 366():193-201. PubMed ID: 1676844
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin E induces morphological differentiation and increases the effect of ionizing radiation on neuroblastoma cells in culture.
    Prasad KN; Ramanujam S; Gaudreau D
    Proc Soc Exp Biol Med; 1979 Sep; 161(4):570-3. PubMed ID: 482292
    [No Abstract]   [Full Text] [Related]  

  • 26. Human neuroblastoma cells produce the NF-kappa B-like HIV-1 transcription activator during differentiation.
    Kurata S; Wakabayashi T; Ito Y; Miwa N; Ueno R; Marunouchi T; Kurata N
    FEBS Lett; 1993 Apr; 321(2-3):201-4. PubMed ID: 8477851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface glycoprotein characteristic of the differentiated state of neuroblastoma C-1300 cells.
    Brown JC
    Exp Cell Res; 1971 Dec; 69(2):440-2. PubMed ID: 5163635
    [No Abstract]   [Full Text] [Related]  

  • 28. HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells.
    Zhang X; Hamada J; Nishimoto A; Takahashi Y; Murai T; Tada M; Moriuchi T
    J Cell Mol Med; 2007; 11(2):299-306. PubMed ID: 17488478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation-inducing agents stably convert human neuroblastoma I-type cells to neuroblastic (N) or nonneuronal (S) neural crest cells.
    Ross RA; Spengler BA; Rettig WJ; Biedler JL
    Prog Clin Biol Res; 1994; 385():253-9. PubMed ID: 7972217
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of nerve growth factor on neuroblast cultures from C 1300 neuroblastoma].
    Hermetet JC; Ciesielski-Treska J; Mandel P
    C R Seances Soc Biol Fil; 1972; 166(8):1120-3. PubMed ID: 4660180
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical and morphological study of adriamycin-induced changes in murine neuroblastoma cells.
    Schengrund CL; Sheffler BA
    Oncology; 1982; 39(3):185-90. PubMed ID: 7078939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of 5-bromodeoxyuridine on gene expression in mammalian cells].
    Koyama H
    Tanpakushitsu Kakusan Koso; 1972 Jun; 17(6):461-9. PubMed ID: 4403868
    [No Abstract]   [Full Text] [Related]  

  • 33. Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.
    Feyles V; Dixon WT; Sikora LK; McGarry RC; Jerry LM
    Cancer Immunol Immunother; 1991; 32(5):261-72. PubMed ID: 1847843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of cell surface antigens accompanies morphological differentiation of human neuroblastoma cell lines.
    Reynolds CP; Maples J
    Prog Clin Biol Res; 1985; 175():13-37. PubMed ID: 2986170
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased level of prolactin gene sequences in bromodeoxyuridine treated GH cells.
    Biswas DK; Hanes SD
    Nucleic Acids Res; 1982 Jul; 10(13):3995-4008. PubMed ID: 7111026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The synthesis and degradation of poly(a)-containing mRNAs in mouse neuroblastoma cells treated with dibutyryl cAMP or with Ro20-1724.
    Morrison MR; Hall CL; Pardue S; Brodeur R; Baskin F; Rosenberg RN
    J Neurochem; 1980 Jan; 34(1):50-8. PubMed ID: 6108985
    [No Abstract]   [Full Text] [Related]  

  • 37. 5-Bromo-2'-deoxyuridine induces S 100 protein in human neuroblastoma cells in culture.
    Tsunamoto K; Imashuku S; Hibi S; Esumi N; Kato K
    Prog Clin Biol Res; 1988; 271():327-36. PubMed ID: 3406006
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression of SV40 T antigen in transformed hamster cells by chronic treatment with 5-bromo-2-deoxyuridine.
    Kreider JW; Del Villano B; Shoff WH; Davidson EA
    Cancer Res; 1972 Oct; 32(10):2148-55. PubMed ID: 4343009
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of 5-bromodeoxyuridine (BUdR) on experimental metastasis.
    Zeidman I
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):827-35. PubMed ID: 4701271
    [No Abstract]   [Full Text] [Related]  

  • 40. Induced differentiation of clonal rat nerve and glial cells.
    Schubert D
    Neurobiology; 1974; 4(6):376-87. PubMed ID: 4453351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.